English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
ASCO 2014: Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer
ASCO 2014: Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast...
ASCO 2014: LHRH analogue goserelin helps preserve fertility among women undergoing chemotherapy for hormone receptor-negative breast cancer
ASCO 2014: LHRH analogue goserelin helps preserve fertility among women undergoing chemotherapy for hormone...
Guideline update recommends tamoxifen for up to 10 years for women with non-metastatic hormone receptor positive breast cancer
Guideline update recommends tamoxifen for up to 10 years for women with non-metastatic hormone receptor positive...
Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer link
Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer...
Delaying androgen deprivation therapy may be safe for men with prostate cancer relapse detected by PSA testing
Delaying androgen deprivation therapy may be safe for men with prostate cancer relapse detected by PSA testing
IMPAKT: Molecular subtype of a breast cancer relapse influences patient post-relapse survival
IMPAKT: Molecular subtype of a breast cancer relapse influences patient post-relapse survival
IMPAKT: Therapeutic effect and markers of response of palbociclib in HER2-positive breast cancer models
IMPAKT: Therapeutic effect and markers of response of palbociclib in HER2-positive breast cancer models
IMPAKT: Combination of mTOR and AKT inhibitors in patients with advanced breast cancer
IMPAKT: Combination of mTOR and AKT inhibitors in patients with advanced breast cancer
HRT impact on genes involved in breast cancer
HRT impact on genes involved in breast cancer
Mayo Clinic launches 50-gene cancer panel test
Mayo Clinic launches 50-gene cancer panel test
<1...8485868788...105>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top